Institut für Klinische Chemie und Laboratoriumsmedizin
Klinikum / Johannes Gutenberg-Universität Mainz
Forschungsprojekte
Ergebnisse pro Seite:
25
2024 - 2022
A Randomized Open Label Phase 1/2 Study of INCB001158 Combined With Subcutaneous (SC) Daratumumab, Compared To Daratumumab SC, in Participants With Relapsed or Refractory Multiple Myeloma- Dr. med. Markus Munder,
- Prof. Dr. med. Georg Heß
2022 - 2026
A Phase III Randomized, Open-Label, Multicenter Study to Determine the Efficacy and Safety of Durvalumab in Combination With Tremelimumab and Enfortumab Vedotin or Durvalumab in Combination With Enfortumab Vedotin for Perioperative Treatment in Patients Ineligible for Cisplatin or Who Refuse Cisplatin Undergoing Radical Cystectomy for Muscle InvasiveBladder Cancer (VOLGA)- PD Dr. med. Maximilian Brandt,
- PD Dr. Rene Mager,
- Dr. Anita Thomas
2021 - 2029
ALLTogether1 – A Treatment study protocol of the ALLTogether Consortium for children and young adults (1-45 years of age) with newly diagnosed acute lymphoblastic leukaemia (ALL)- Univ.-Prof. Dr. med. Jörg Faber,
- Dr. med. Arthur Wingerter,
- Dr. med. Alexandra Russo
2018 - 2019
FORT-1:Phase 2/3 study of rogaratinib (BAY 1163877) vs chemotherapy in patients with FGFR-positive locally advanced or metastatic urothelial carcinoma- Prof. Dr. Georg Bartsch,
- Prof. Dr. Igor Tsaur,
- PD Dr. Thomas Höfner
2018 - 2022
FORT-2: Phase 1b/2 study of rogaratinib (BAY 1163877) in combination with atezolizumab in urothelial carcinoma- Prof. Dr. Georg Bartsch,
- Prof. Dr. Igor Tsaur,
- PD Dr. Thomas Höfner
2016 - 2017
Adapting conCLIP to illuminate the role of RNA-binding proteins (RBPs) in pathophysiological processes- Prof. Dr. Sven Danckwardt
2015 - 2017
Pathogenesis of the Antiphospholipid Syndrome- Dr. Nadine Müller-Calleja,
- Univ.-Prof. Dr. Karl Lackner
2014 - 2015
Untersuchungen über die Bedeutung der von-Willebrand-Faktor-Parameter sowie ADAMTS13 zur Pathogenese der Arteriosklerose bei chronischen Schmerzpatienten- Univ.-Prof. Dr. Inge Scharrer,
- Dr. Rita Laufenberg,
- Univ.-Prof. Dr. Christian Werner
2014 - 2015
A role for polymorphonuclear neutrophils in the pathogenesis of the anti-phospholipid syndrome- Univ.-Prof. Dr. Markus Radsak
2013 - 2015
Untersuchungen zur Antikörperentstehung bei der TTP bei ADAMTS13-KO-Mäusen und Wildtypmäusen- Univ.-Prof. Dr. Inge Scharrer,
- Cecilia Perera
2013 - 2015
Untersuchungen über die Genese bei "jugendlichen" Schlaganfällen unter besonderer Berücksichtigung von ADAMTS13- Univ.-Prof. Dr. Inge Scharrer,
- PD Dr. Klaus Gröschel
2013 - 2014
Untersuchungen zur Pathogenese und zum Verlauf von hereditärer TTP- Univ.-Prof. Dr. Inge Scharrer,
- Dr. Tanja Falter,
- Prof. Dr. Bernhard Lämmle
2013 - 2015
Untersuchung des Komplementsystems bei trockener und feuchter AMD- Univ.-Prof. Dr. Inge Scharrer
2013 - 2014
Untersuchungen über Zusammenhang von Infektionsserologie und Antiphospholipidsyndrom sowie über die klinische Symptomatik bei APS- Univ.-Prof. Dr. Inge Scharrer,
- Univ.-Prof. Dr. Karl Lackner
2013 - 2014
TREND-seq – A highly multiplexed sequencing approach to interrogate transcriptome 3’ end diversity in health and disease- Univ.-Prof. Dr. Sven Danckwardt,
- Anton Ogorodnikov
2013 - 2016
miRNAs involved in the higher level network control of the plasmatic coagulation system- Dr. James Nourse,
- Prof. Dr. Sven Danckwardt
2013
Role of glutathione peroxidase in the pathogenesis of atherosclerosis- Univ.-Prof. Dr. Karl Lackner,
- Prof. Dr. Michael Torzewski
2013 - 2014
Antiphospholipid antibodies in the general population- Univ.-Prof. Dr. Karl Lackner,
- Dr. Davit Manukyan
2013 - 2019
In vivo model of thrombus induction in the antiphospholipid syndrome- Univ.-Prof. Dr. Karl Lackner,
- Dr. Davit Manukyan